Establishment Labs Holdings Inc. (NASDAQ:ESTA)
| Market Cap | 1.84B+55.8% |
| Revenue (ttm) | 245.82M+38.6% |
| Net Income | -38.89M+56.1% |
| EPS | -1.31+57.1% |
| Shares Out | 29.43M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 107,991.152 |
| Open | 63.41 |
| Previous Close | 63.85 |
| Day's Range | 61.86 - 63.41 |
| 52-Week Range | 38.38 - 97.59 |
| Beta | 1.06 |
| Analysts | Buy |
| Price Target | 102.00(+63.46%) |
| Earnings Date | Nov 4, 2026 |
Insiders here have filed 6 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
About ESTA
Establishment Labs Holdings Inc. operates as a medical technology enterprise specializing in the creation and commercialization of devices for aesthetic and reconstructive plastic surgery. The company is primarily recognized for its silicone gel-filled breast implants, sold under the Motiva Implants brand. Among these are the Motiva Ergonomix and Motiva Ergonomix2, which are distinctive, gravity-sensitive, round, soft silicone-gel-filled implants. Furthermore, Establishment Labs provides the Motiva Flora Tissue Expander for breast tissue and distributes the Puregraft range of products, utilized for the harvesting and redistribution of autologous adipose tissue. The firm markets its offerings across Europe, Latin America, the Asia-Pacific region, and other global markets, leveraging both a direct sales force and exclusive distributors. Founded in 2004, Establishment Labs has its main office situated in Alajuela, Costa Rica.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$ESTA stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in ESTA holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by ESTA's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
ESTA Estimated quarterly lobbying spending
Source: U.S. Senate LDA
ESTA Revenue by Segment or Geography
| Segment | Revenue | % of All |
|---|---|---|
| OUS | $42.85M | 63.44% |
| US | $24.69M | 36.56% |
As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New ESTA patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to ESTA from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in ESTA
| ETF | Est. Holding Size |
|---|---|
| IWMiShares Russell 2000 ETF | $45.41M |
| IWOiShares Russell 2000 Growth ETF | $16.16M |
| VTWOVanguard Russell 2000 ETF | $10.80M |
| FYCFirst Trust Small Cap Growth AlphaDEX Fund | $7.66M |
| TMSLT. Rowe Price Small-Mid Cap ETF | $5.76M |
| VHTVanguard Health Care ETF | $3.92M |
Estimated from each fund’s disclosed top holdings × AUM
ESTA Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from ESTA’s recent data — informational, not investment advice